Xeris Biopharma Holdings, Inc. XERS
10.49 USD +0.32 (+3.15%)
Nov 3, 2026, 3:23 PM EST
10.17 Day range 10.56
5.25 52-week range 11.42
- YTD
- +33.63%
- 1 year
- +5.96%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 291.85M | 203.07M | 163.91M | 110.25M | 49.59M | |
| 249.28M | 166.24M | 135.27M | 87.61M | 36.27M | |
| 24.90M | -33.65M | -44.01M | -81.94M | -115.16M | |
| 554.00K | -54.84M | -62.26M | -94.66M | -122.72M |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 111.04M | 71.62M | 67.45M | 121.97M | 67.27M | |
| 383.53M | 323.06M | 322.60M | 344.52M | 304.36M | |
| 369.84M | 352.68M | 329.38M | 299.33M | 209.13M | |
| 258.10M | 271.45M | 229.19M | 198.06M | 88.07M | |
| 13.69M | -29.61M | -6.78M | 45.19M | 95.23M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 28.63M | -36.98M | -47.02M | -102.89M | -95.53M | |
| -696.00K | 4.88M | -6.00M | 34.46M | 97.96M | |
| 11.39M | 36.17M | -1.61M | 127.47M | 27.25M | |
| -696.00K | -868.00K | -2.26M | -524.00K | -1.08M | |
| 39.32M | 4.07M | -54.64M | 59.04M | 29.67M |